Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
Vanitha N. Sivalingam, Ayşe Latif, Sarah Kitson, et al.
British Journal of Cancer (2019) Vol. 122, Iss. 1, pp. 62-71
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The updated landscape of tumor microenvironment and drug repurposing
Ming-Zhu Jin, Weilin Jin
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 852
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
Monika Janda, Kristy Robledo, Val Gebski, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 1, pp. 143-151
Open Access | Times Cited: 67
Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling
Huamei Wei, Zuoming Xu, Liucui Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 59
Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
Yun Chen
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 52
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance
Mahboubeh Tajaldini, Amirhoushang Poorkhani, Taghi Amiriani, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175991-175991
Closed Access | Times Cited: 22
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Constanze Banz‐Jansen, Laureen P. Helweg, Barbara Kaltschmidt
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3412-3412
Open Access | Times Cited: 29
Metabolic reprogramming and interventions in endometrial carcinoma
Jiajia Li, Hongmei Yang, Lingyi Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114526-114526
Open Access | Times Cited: 19
Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes
Xiao Yang, Yuan Cheng, Jingyi Zhou, et al.
Advanced Science (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 24
Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma
Lisheng Zhu, Jingyu Liu, Meng-jun Qiu, et al.
Biomaterials (2022) Vol. 288, pp. 121711-121711
Open Access | Times Cited: 22
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
Pengzhu Huang, Xiangqin Fan, Hongfei Yu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
Adrian L. Harris
British Journal of Cancer (2019) Vol. 122, Iss. 1, pp. 1-3
Open Access | Times Cited: 37
Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines
I‐Lun Hsin, Huang‐Pin Shen, Huiyi H. Chang, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2916-2916
Open Access | Times Cited: 26
Glucose metabolism reprogramming in gynecologic malignant tumors
Jianhong Ma, Zhiqiang Yao, Liangjian Ma, et al.
Journal of Cancer (2024) Vol. 15, Iss. 9, pp. 2627-2645
Open Access | Times Cited: 2
Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies
Wanlin Dai, Renhao Guo, Xinni Na, et al.
Redox Biology (2024) Vol. 73, pp. 103205-103205
Open Access | Times Cited: 1
PI3K/AKT signaling alters glucose metabolism in uterine microenvironment of women with idiopathic recurrent spontaneous miscarriage
D Sherpa, Sanjukta Dasgupta, Imon Mitra, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119834-119834
Closed Access | Times Cited: 1
The Role of Hypoxia in Endometrial Cancer
Yarely M. Salinas-Vera, Dolores Gallardo‐Rincón, Érika Ruiz-García, et al.
Current Pharmaceutical Biotechnology (2021) Vol. 23, Iss. 2, pp. 221-234
Closed Access | Times Cited: 11
Fever-Inducible Lipid Nanocomposite for Boosting Cancer Therapy through Synergistic Engineering of a Tumor Microenvironment
Ding Qu, Yue Qin, Yuping Liu, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 29, pp. 32301-32311
Closed Access | Times Cited: 11
Metformin Impacts Human Syncytiotrophoblast Mitochondrial Function from Pregnancies Complicated by Obesity and Gestational Diabetes Mellitus in a Sexually Dimorphic Manner
Jessica F. Hebert, Leslie Myatt
Antioxidants (2023) Vol. 12, Iss. 3, pp. 719-719
Open Access | Times Cited: 3
Perspectives of metformin use in endometrial cancer and other gynaecological malignancies
Bartłomiej Barczyński, Karolina Frąszczak, Jan Kotarski
Journal of drug targeting (2021) Vol. 30, Iss. 4, pp. 359-367
Closed Access | Times Cited: 7
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
Daniele Boso, Martina Tognon, Matteo Curtarello, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 2
Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment
T.M. Kecheryukova, Vladimir S. Trifanov, A. A. Shulg, et al.
South Russian Journal of Cancer (2024) Vol. 5, Iss. 2, pp. 35-42
Open Access
Combined Oxygen-enhanced MRI and perfusion imaging detect hypoxia modification from banoxantrone and atovaquone and track their differential mechanisms of action
James P.B. O’Connor, Victoria Tessyman, Ross A. Little, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 10, pp. 2565-2574
Open Access
Rewired Cellular Metabolic Profiles in Response to Metformin under Different Oxygen and Nutrient Conditions
Shan Liu, Jumpei Washio, Satoko Sato, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 989-989
Open Access | Times Cited: 3
Platycodin D inhibits the proliferation, invasion and migration of endometrial cancer cells by blocking the PI3K/Akt signaling pathway via ADRA2A upregulation
Ni Zhen, Zhuoma Dawa, Deji Suolang, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 1
Metformin is a metabolic modulator and radiosensitiser in rectal cancer
Croí E. Buckley, Rebecca O’Brien, Timothy Nugent, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top